News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
261 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (335)
2 (311)
3 (237)
4 (70)
6 (2)
7 (48)
8 (54)
9 (56)
10 (84)
11 (40)
13 (1)
14 (80)
15 (90)
16 (78)
17 (59)
18 (31)
20 (1)
21 (91)
22 (78)
23 (75)
24 (68)
25 (25)
26 (1)
28 (4)
29 (222)
30 (262)
31 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
26
28
29
30
31
Business
NEOMED-LABS Renews Strategic Agreement with GSK
Laval headquartered NEOMED-LABS announces today a 3-year extension of their strategic agreement with GSK.
May 31, 2018
·
2 min read
Genetown
Commonwealth Diagnostics International Re-Launches IBSchek™ at Digestive Disease Week® (DDW) June 2018
Commonwealth Diagnostics International (CDI), Inc. announced the commercial re-launch of IBSchek™.
May 31, 2018
·
6 min read
BioMidwest
BrainScope Initiates Teenage and Young Adult Multi-Site Clinical Study for Concussion Assessment Product
BrainScope announced today the initiation of a large, multi-site clinical research study enrolling subjects ages 13-25 years who sustained a head injury from a variety of causes, including sports-related head injuries
May 31, 2018
·
3 min read
Policy
Kurin, Inc. Sues Magnolia Medical for Misleading Consumers about FDA Clearance and Efficacy
Kurin Inc. has sued Magnolia Medical Technologies in the U.S. District Court for the Southern District of California for violations of the Lanham Act.
May 31, 2018
·
2 min read
Business
Canopy Rivers Announces Board of Directors and Key Additions to Management Team
Canopy Rivers Corporation (“Canopy Rivers”, or the “Company”) is pleased to announce its newly appointed, majority independent Board of Directors, as well as a number of strategic appointments to its management team.
May 31, 2018
·
11 min read
Biotech Beach
Good Samaritan Hospital Receives Get With The Guidelines-Stroke Silver Plus Quality Achievement Award
Good Samaritan Hospital has received the American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Silver Plus Quality Achievement Award.
May 31, 2018
·
2 min read
FDA
Encision Inc. Applauds the FDA’s Safety Communication On The Dangers Of Monopolar Electrosurgery
Encision Inc. applauded the FDA’s issuance of a safety communication.
May 31, 2018
·
3 min read
Drug Development
Curis Announces FDA Fast Track Designation for Fimepinostat (CUDC-907) Development in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Curis, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the development of fimepinostat in patients with relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy.
May 31, 2018
·
3 min read
Policy
Sarissa Capital Issues Statement On Ironwood Pharmaceuticals
Sarissa Capital Management LP today made the following statement regarding Ironwood Pharmaceuticals, Inc.
May 31, 2018
·
2 min read
Pharm Country
Realm Therapeutics to Present at June 2018 Investor Conferences
Realm Therapeutics plc (AIM: RLM), a clinical stage biopharmaceutical company focused on developing novel therapeutics in immune-mediated diseases, today announces that the Company will participate in several investor conferences in June.
May 31, 2018
·
3 min read
Previous
14 of 27
Next